comparemela.com

Page 6 - Thomas Flaten News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ensysce Biosciences : Earnings Webcast FY 2022

Corporate Update Call April 11, 2023 Ensysce Biosciences, Inc. - Corporate. | April 13, 2023

United statesDave humphreyLynn kirkpatrickBill schmidtThomas flatenWilliam schmidtEnsysce biosciences incCorporate update callUpdate callChief executiveChief medicalChief financial officerLake street capitalEnsysce biosciencesCorporate updateChief executive officer

DiaMedica Therapeutics Inc (NASDAQ:DMAC) Q4 2022 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics ReMEDy2 Update Conference Call.

Tanya lewisKirsten gruisScott kellenDominic cundariAlexander nowakJulie davesAlex nowakThomas flatenRick paulsDiamedica therapeutics incCraig hallum capital groupClinical development operationsHealth photoDiamedica therapeuticsCall transcript marchInvestor relations

Achieve Life Sciences, Inc (NASDAQ:ACHV) Q4 2022 Earnings Call Transcript

Operator: Hello and welcome to the Achieve Life Sciences Fourth Quarter 2022 Earnings Conference Call and Webcast. As a reminder, this conference is being recorded.

Nicole jonesMichael higginsThomas flatenNafis al sadnanCindy jacobsJohn bencichNancy rigottiLadenburg thalmannSociety for research on nicotineBiggest health insurance companiesLife sciences incLife sciences fourth quarterAchieve life sciencesCall transcript marchAchieve life sciences fourth quarterConference call

Aquestive Therapeutics, Inc (NASDAQ:AQST) Q4 2022 Earnings Call Transcript

Operator: Good morning, and welcome to the Aquestive Therapeutics Fourth Quarter and Full Year 2022 Conference Call. At this time, all participants are in a listen only-mode.

United statesSteve wargackiJason butlerAndreas argyridesThomas flatenGary nachmanErnie tothDan barberRd steve wargackiRam selvarajuKen truittJames malloyFrancois briseboisBennett watsonKen marshallAlliance global partners

Castle Biosciences, Inc (NASDAQ:CSTL) Q4 2022 Earnings Call Transcript

Operator: Good afternoon, and welcome to Castle Biosciences Fourth Quarter 2022 Conference Call. As a reminder, today s call is being recorded.

United statesSan diegoJi namMason karikoKyle miksonThomas flatenMark massaroPuneet soudaCatherine schultzDerek maetzoldCastle biosciencesFrank stokesCamilla zuckeroCastle biosciences incExchange commissionAlthea san diego lab

vimarsana © 2020. All Rights Reserved.